Skip to main content
. 2020 Aug 4;11:1182. doi: 10.3389/fphar.2020.01182

Table 1.

Biophysical properties of mutant channels and inhibition of late INa by drugs.

Activation Inactivation Recovery
V1/2 (mV) Slope, κ (mV) n V1/2 (mV) Slope, κ (mV) n A1 τfast (ms) τslow (ms) n
WT -47.3 ± 1.0 4.8 ± 0.8 7 -90.7 ± 1.8 -12.9 ± 1.8 6 0.32 24.0 164.0 7
N1325S(control) -55.2 ± 0.5* 4.1 ± 0.6 13 -86.1 ± 1.3 -14.3 ± 2.8 13 0.35 23.6 170.0 13
N1325S(MEX) -55.3 ± 0.5 4.9 ± 0.4 6 -95.62 ± 0.5 -10.6 ± 0.5 5 0.09 67.2 762.2 6
R1623Q(control) -49.6 ± 0.6 5.8 ± 0.6 7 -105.9 ± 0.7* -11.3 ± 0.6 6 0.16 35.3 2356.3 9
R1623Q(MEX) -51.7 ± 0.7 6.3 ± 0.7 6 -110.0 ± 0.8 -11.0 ± 0.7 6 0.16 52.3 5007.5 7
M1652R(control) -49.9 ± 0.8 4.4 ± 0.3 6 -85.1 ± 1.0* -14.4 ± 2.2 6 0.12 37.7 370.8 8
M1652R(MEX) -52.2 ± 0.7 5.6 ± 0.6 6 -91.4 ± 2.0 -16.0 ± 2.2 6 0.16 49.1 904.2 8

*P < 0.05 compared with WT; P < 0.05 compared with control.